Skip to main content
IDXG logo

IDXG · Interpace Biosciences, Inc.

Track IDXG — free
$3.25 At close · Feb 25
Market Cap
$42.19M
Shares
5.54M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Robert Gorman Resigned 2023-12-12
Robert Gorman Resigned 2023-12-12
Edward Chan Resigned 2023-11-16
Christopher McCarthy Appointed 2023-08-02
Christopher McCarthy Appointed 2023-04-25
Thomas Freeburg Resigned 2022-10-04
Dr. Vijay Aggarwal Appointed 2022-01-27
Eric B. Lev Resigned 2022-01-27
Thomas J. Freeburg Appointed 2021-02-04
Thomas Burnell Appointed 2020-11-25
Jack E. Stover Retired 2020-11-25
Jack E. Stover Resigned 2020-11-25
Thomas W. Burnell Appointed 2020-11-25
Thomas W. Burnell Appointed 2020-11-25
Jack E. Stover Resigned 2020-11-25
Jack E. Stover Appointed 2020-07-14
Joseph Keegan, PhD Appointed 2020-07-14
Jeff Salzman Appointed 2020-01-31
Fred Knechtel Appointed 2020-01-31
Ron Rocca Appointed 2020-01-31
James Early Retired 2020-01-31
James Early Resigned 2020-01-31
Fred Knechtel Appointed 2020-01-31
Felice Schnoll-Sussman Resigned 2020-01-28
Fortunato Ron Rocca Appointed 2020-01-28
Key facts CIK 1054102 CUSIP 46062X303 Visit website Investor relations